Changeflow GovPing Healthcare FDA Variance Application from William Moore - P...
Routine Consultation Added Consultation

FDA Variance Application from William Moore - Public Comment

Email

Summary

The FDA is accepting public comments on a variance application submitted by William Moore. The comment period is open until March 13. This action pertains to a specific application for a variance.

What changed

The Food and Drug Administration (FDA) is seeking public comment on a variance application submitted by William Moore. The application details are available for review, with a redacted version provided for public access. The FDA's Center for Devices and Radiological Health (CDRH) is listed as an author.

Interested parties are invited to submit comments on this variance application. The deadline for submitting comments is March 13. While the specific nature of the variance is not detailed in the provided text, regulated entities, particularly those in the drug and medical device sectors, should review the application and consider submitting comments if relevant to their operations.

What to do next

  1. Review the variance application from William Moore.
  2. Submit comments to the FDA by March 13 if relevant.

Source document (simplified)

Content

There are no documents available to view or download

Attachments 2

Variance Application from William Moore

Restricted: Personally Identifiable Information

More Information
- Author(s) CDRH

Variance Application from William Moore_Redacted

More Information
- Author(s) CDRH
Download

Classification

Agency
FDA
Compliance deadline
March 13th, 2026 (4 days ago)
Instrument
Consultation
Legal weight
Non-binding
Stage
Consultation
Change scope
Minor

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Geographic scope
National (US)

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Medical Devices Pharmaceuticals

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.